Joseph C Quintavalla, Age 70New Providence, NJ

Joseph Quintavalla Phones & Addresses

New Providence, NJ

New City, NY

Copake, NY

Craryville, NY

Copake Falls, NY

Summit, NJ

Bronx, NY

New Providnce, NJ

53 Woodbine Cir, New Providence, NJ 07974 (908) 581-0709

Show more

Social networks

Joseph C Quintavalla

Linkedin

Work

Company: Novartis 2004 Address: East Hanover, NJ Position: Associate director, regulatory affairs, oncology bu

Education

Degree: PhD School / High School: University of Medicine and Dentistry of New Jersey -New Jersey Medical School 1991 Specialities: Biochemistry

Industries

Pharmaceuticals

Mentions for Joseph C Quintavalla

Resumes & CV records

Resumes

Joseph Quintavalla Photo 11

Drug Regulatory Affairs

Position:
Associate Director, Regulatory Affairs, Oncology BU at Novartis
Location:
Greater New York City Area
Industry:
Pharmaceuticals
Work:
Novartis - East Hanover, NJ since 2004
Associate Director, Regulatory Affairs, Oncology BU
Bayer HealthCare 2012 - 2013
Regulatory
Novartis Pharmaceuticals - East Hanover, NJ 1991 - 2004
Research Principal Investigator, Drug Discovery
University of Medicine and Dentistry of NJ - New Brunswick, NJ 1989 - 1991
Doctoral Candidate, Department of Biochemistry
CIBA-Geigy Pharmaceuticals - Arsley, NY 1979 - 1988
Scientist
Education:
University of Medicine and Dentistry of New Jersey -New Jersey Medical School 1991
PhD, Biochemistry
New York University 1979
Master of Science (MS), Biology
City University of New York City College 1976
Bachelor of Science (BS), Biology

Publications & IP owners

Us Patents

High Throughput Functional Genomic Screening Methods For Osteoarthritis

US Patent:
2006018, Aug 24, 2006
Filed:
Apr 16, 2004
Appl. No.:
10/553520
Inventors:
Dale Bodian - Whippany NJ, US
Sherif Daouti - Hasbrouck Heights NJ, US
Chandrika Kumar - Acton MA, US
Brian Latario - Groton MA, US
Joseph Quintavalla - New Providence NJ, US
International Classification:
C12Q 1/68
US Classification:
435006000
Abstract:
High-throughput functional screening assays are provided that identify genes and gene products that are associated with the pathogenesis of osteoarthritis (OA) in chondrocytes. In addition, genes and gene products identified by such functional assays are also provided. The genes and gene products provided herein are useful inter alia for diagnosing OA in individuals and as drug targets for identifying drugs to treat OA.

NOTICE: You may not use PeopleBackgroundCheck or the information it provides to make decisions about employment, credit, housing or any other purpose that would require Fair Credit Reporting Act (FCRA) compliance. PeopleBackgroundCheck is not a Consumer Reporting Agency (CRA) as defined by the FCRA and does not provide consumer reports.